Rule also permits affiliates of the Company to sell their Rule shares under Rule without complying with the holding period requirements of Rule All holders of Rule shares, however, are required by that rule to wait until 90 days after the date of the final prospectus in respect of the Proposed Offering before selling those shares under Rule , subject to the expiration of the lock-up agreements entered into in connection with the Proposed Offering.
Skip to main navigation. News Release. Jul 19, PDF Version. RNS Number : F. About MaxCyte MaxCyte is a leading provider of cell-engineering platform technologies to advance innovative cell-based research, development and potential commercialization of next-generation cell therapies. Part III - Summary of the requirements of Rule and Rule Rule In general, under Rule as currently in effect, once the Company has been subject to public company reporting requirements of Section 13 or 15 d of the US Securities Exchange Act of the " Exchange Act " for at least 90 days, an eligible stockholder is entitled to sell such shares without complying with the manner of sale, volume limitation or notice provisions of Rule , subject to compliance with the public information requirements of Rule Rule Rule generally allows a stockholder who was issued shares under a written compensatory plan or contract and who is not deemed to have been an affiliate of the Company during the immediately preceding 90 days, to sell these shares in reliance on Rule , but without being required to comply with the public information, holding period, volume limitation or notice provisions of Rule Terms and conditions relating to the use and distribution of this information may apply.
For further information, please contact rns lseg. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services.
Investor Tools. MaxCyte Inc. This is general information only and not financial advice. Before making an investment decision, you should read the relevant PDS and with the assistance of a financial adviser consider if it is appropriate for your circumstances. PDSs are available at www. No member of VanEck group of companies gives any guarantee or assurance as to the repayment of capital, the payment of income, the performance, or any particular rate of return of any VanEck funds.
Past performance is not a reliable indicator of future performance. The underlying shares are held on trust for the owners of the CDI, who have full economic rights over them. But they can be bought and sold through most UK stockbrokers, often — though not always — for the same trading fee as a UK share. The main advantage of the CDI is simply to make settlement of trades and custody of stocks easier for foreign securities.
The CREST system also offers the option of making and receiving payments in euros and US dollars, although not all brokers will offer this. The most obvious disadvantage of CDIs is that only a limited number of international stocks are available in this way. The CDI arrangements are geared towards larger stocks in major Western economies and even where a market is covered, not all companies listed there will be available. When quoting the sterling price for a foreign security, the mark-up will usually range from 0.
This is not a deficiency of the CDI system itself, just a reality of the market. Using CDIs can still be cost-effective relative to the costs of trading directly overseas, since your broker does not need to incorporate other costs of an international service.
At first glance, it looks as if owning a CDI means that you are further removed from owning the underlying stock — but the difference is smaller than you might think. Although the structure of the CDI means that the underlying stock is held in the name of CREST rather than in your name being on the register of shareholders, the same is true for most share ownership today.
As with any stock held in nominee, you still have economic rights over the share underlying the CDI. You will receive dividends and CREST will process corporate actions such as stock splits and rights issues. The safety of brokerage account holdings is an extremely complicated topic, and just as with all nominee holdings there are some theoretical risks. However, the fact that CDIs are issued by the central securities depository — a crucial part of the financial infrastructure — means that they are unlikely to be the weakest link in the custody chain.
In general, the tax treatment of CDIs is the same as applies to the underlying shares. In particular, this means that:. Close Menu International investing. Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership. Please contact Member Services on support investsmart. It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in. Registration for this event is available only to Eureka Report members. View our membership page for more information. Registration for this event is available only to Intelligent Investor members. Already a member? Log in. CDIs came into existence because it is often not possible for companies incorporated overseas to allow share transfers through the ASX's paperless settlement system.
In many cases, though, they trade on a different basis, for example, for-one. Information is general financial product advice. You should consider your own personal objectives, financial situation and needs before making any investment decision and review the Product Disclosure Statement. The RE may own, buy or sell the shares suggested in this article simultaneous with, or following the release of this article.
0コメント